New Recruiting Trial: Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
WHY IT MATTERS
This trial directly addresses a common complication in premature infants where improper oxygen management can cause lasting lung damage, making oxygen saturation targeting strategies critical for improving long-term outcomes in this vulnerable population.
Researchers at the University of Alabama at Birmingham are looking for premature babies to join a study about pulmonary hypertension—a condition where blood pressure in the lungs gets too high. The study will test different oxygen level targets to see which approach helps prevent or reduce lung problems in preterm infants. This trial is now actively recruiting participants and is expected to start in April 2026.
NCT ID: NCT06373289 Title: Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants Status: RECRUITING Phase: NA Sponsor: University of Alabama at Birmingham Start date: 2026-04-01 URL: https://clinicaltrials.gov/study/NCT06373289 Source: UniteRare clinical trials database
YOU CAN ACT ON THIS
If you have a premature infant or know one in a NICU, ask your neonatologist whether your baby meets eligibility criteria for this trial at University of Alabama at Birmingham.